['bronchiectasis']
['ciprofloxacin (bayq3939) dry powder for inhalation', 'ciprofloxacin (bayq3939) dry powder for inhalation', 'placebo', 'placebo']

        Inclusion Criteria:

          -  Patients with a proven and documented diagnosis of non CF idiopathic or post
             infectious bronchiectasis

          -  Stable pulmonary status and stable regimen of standard treatment at least for the past
             4 weeks

        Exclusion Criteria:

          -  Forced expiratory volume in 1 second (FEV1) <30% or >90% predicted

          -  Active allergic bronchopulmonary aspergillosis

          -  Active and actively treated non tuberculosis mycobacterial (NTM) infection or
             tuberculosis

          -  Primary diagnosis of Chronic obstructive pulmonary disease (COPD)
      